Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy ENDRA Life Sciences stock
Own ENDRA Life Sciences stock in just a few minutes.
ENDRA Life Sciences Inc is a diagnostics & research business based in the US. ENDRA Life Sciences shares (NDRA) are listed on the NASDAQ and all prices are listed in US Dollars. ENDRA Life Sciences employs 18 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in ENDRA Life Sciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NDRA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
ENDRA Life Sciences share price
Use our graph to track the performance of NDRA stocks over time.ENDRA Life Sciences shares at a glance
Information last updated 2021-04-21.
| 52-week range | $0.60 - $3.10 |
|---|---|
| 50-day moving average | $2.45 |
| 200-day moving average | $1.54 |
| Wall St. target price | $5.75 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.63 |
Buy ENDRA Life Sciences shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ENDRA Life Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ENDRA Life Sciences financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -90.19% |
| Return on equity TTM | -196.57% |
| Profit margin | 0% |
| Book value | $0.21 |
| Market capitalisation | $95.7 million |
TTM: trailing 12 months
Shorting ENDRA Life Sciences shares
There are currently 1.2 million ENDRA Life Sciences shares held short by investors – that's known as ENDRA Life Sciences's "short interest". This figure is 304.4% up from 294,245 last month.
There are a few different ways that this level of interest in shorting ENDRA Life Sciences shares can be evaluated.
ENDRA Life Sciences's "short interest ratio" (SIR)
ENDRA Life Sciences's "short interest ratio" (SIR) is the quantity of ENDRA Life Sciences shares currently shorted divided by the average quantity of ENDRA Life Sciences shares traded daily (recently around 2.4 million). ENDRA Life Sciences's SIR currently stands at 0.49. In other words for every 100,000 ENDRA Life Sciences shares traded daily on the market, roughly 490 shares are currently held short.
However ENDRA Life Sciences's short interest can also be evaluated against the total number of ENDRA Life Sciences shares, or, against the total number of tradable ENDRA Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ENDRA Life Sciences's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 ENDRA Life Sciences shares in existence, roughly 30 shares are currently held short) or 0.0303% of the tradable shares (for every 100,000 tradable ENDRA Life Sciences shares, roughly 30 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ENDRA Life Sciences.
Find out more about how you can short ENDRA Life Sciences stock.
ENDRA Life Sciences share dividends
We're not expecting ENDRA Life Sciences to pay a dividend over the next 12 months.
ENDRA Life Sciences share price volatility
Over the last 12 months, ENDRA Life Sciences's shares have ranged in value from as little as $0.6 up to $3.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ENDRA Life Sciences's is 1.2889. This would suggest that ENDRA Life Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ENDRA Life Sciences overview
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. It develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. The company also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Frequently asked questions
More guides on Finder
-
How to buy Krispy Kreme (NDRA.US) stock when it goes public
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
-
How to buy Day One Biopharmaceuticals (DAWN) stock when it goes public
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
-
How to buy Enact Holdings (ACT) stock when it goes public
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
-
How to buy Solid Power (NDRA.US) stock when it goes public
Everything we know about the Solid Power IPO, plus information on how to buy in.
-
How to buy Paymentus Holdings (PAY) stock when it goes public
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
-
How to buy Qiniu Limited (QNIU) stock when it goes public
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
-
How to buy Qiniu Limited (QNIU) stock when it goes public
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
-
How to buy Ximalaya (XIMA) stock when it goes public
Everything we know about the Ximalaya IPO, plus information on how to buy in.
-
How to buy Zeta Global Holdings Corp (ZETA) stock when it goes public
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
-
How to buy Paycor HCM (PYCR) stock when it goes public
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
Ask an Expert